Western Pacific Region Index Medicus

Retraction note: TGF-β1-regulated miR-3691-3p targets E2F3 and PRDM1 to inhibit prostate cancer progression.

Author: Yue-Mei HU ¹ ; Xiao-Li LOU ¹ ; Bao-Zhu LIU ² ; Li SUN ³ ; Shan WAN ¹ ; Lei WU ³ ; Xin ZHAO ¹ ; Qing ZHOU ⁴ ; Mao-Min SUN ³ ; Kun TAO ⁵ ; Yong-Sheng ZHANG ⁶ ; Shou-Li WANG ¹
Author Information

1. Department of Pathology, School of Biology and Basic Medical Sciences, Soochow University, Suzhou 215123, China.
2. Collaborative Innovation Center of Clinical Immunology Between Soochow University and Sihong People's Hospital, Sihong 223900, China.
3. Laboratory Animal Research Center, Soochow University School of Medicine, Suzhou 215123, China.
4. Department of Surgery, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.
5. Department of Pathology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200336, China.
6. Department of Pathology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China.
Publication Type:Journal Article
From: Asian Journal of Andrology 2022;24(6):684-684
CountryChina
Language:English